Title: Granulomatosis with Angitis of Lung treated with Steroids and Rituximab– Case Report and Review of Literature

Authors: Dr Jolsana Augustine, Dr Rajesh V, Dr Latha Abraham, Dr Dantis Immanuel

 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.84

Abstract

Granulomatosis with angitis, formerly termed Wegener’s granulomatosis (WG) is an uncommon autoimmune disease with multisystem involvement, the pathological hallmark of which is necrotizing granulomas with vasculitis. Although it commonly limits itself to involvement of the upper and lower respiratory tracts or kidneys, it may potentially involve any organ. We present the case of a young lady who presented with persistent fever lasting 2 months and right upper lobe consolidation, with laboratory evidence of glomerulonephritis. Serological tests revealed high titres of antibody to proteinase 3 (antineutrophil cytoplasmic antibody – cytoplasmic type- ANCA). A lung biopsy from the left upper lobe revealed necrotizing granulomas with vasculitis, thus clinching the diagnosis. Remission was achieved with a combination of prednisolone with rituximab, complete remission being evidenced as early as 3 weeks of therapy initiation. Steroids were gradually tapered in the maintenance phase and she remains under close follow up for any features of relapse.

Keywords: Granulomatosis with angitis, necrotizing granulomas, small vessel vasculitis, Wegener’s granulomatosis

References

  1. Godman GC, Churg J. Wegener’s granulomatosis: pathology and review of the literature. AMA Arch Pathol. 1954 Dec;58(6):533–53.
  2. Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DRW, Jennette JC, et al. Granulomatosis with Polyangiitis (Wegener’s): An alternative name for Wegener’s Granulomatosis. Arthritis & Rheumatism. 2011 Apr 1;63(4):863–4.
  3. Lee KS, Kim TS, Fujimoto K, Moriya H, Watanabe H, Tateishi U, et al. Thoracic manifestation of Wegener’s granulom-atosis: CT findings in 30 patients. Eur Radiol. 2003 Jan;13(1):43–51.
  4. Voswinkel J, Müller A, Lamprecht P. Is PR3-ANCA Formation Initiated in Wegener’s Granulomatosis Lesions? Granulomas as Potential Lymphoid Tissue Maintaining Autoantibody Production. Annals of the New York Academy of Sciences. 2005 Jun 1;1051(1):12–9.
  5. Mohammad AJ, Mortensen KH, Babar J, Smith R, Jones RB, Nakagomi D, et al. Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA Subtype. J Rheumatol. 2017 Oct;44(10):1458–67.
  6. Stone JH, Hoffman GS, Merkel PA, Min Y-I, Uhlfelder ML, Hellmann DB, et al. A disease-specific activity index for Wegener’s granulomatosis: Modification of the Birmingham Vasculitis Activity Score. Arthritis & Rheumatism. 2001 Apr 1;44(4):912–20.
  7. Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Annals of the Rheumatic Diseases. 2016 Sep 1;75(9):1583–94.
  8. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis. New England Journal of Medicine. 2010 Jul 15;363(3):221–32.
  9. Jones RB, Cohen Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, et al. Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis [Internet]. http://dx.doi.org/10.1056/NEJMoa0909169. 2010 [cited 2018 Nov 9]. Available from: https://www.nejm.org/doi/10.1056/NEJMoa0909169?url_ver=Z39.88-2003& rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dwww.ncbi.nlm.nih.gov
  10. Takala JH, Kautiainen H, Leirisalo-Repo M. Survival of patients with Wegener’s granulomatosis diagnosed in Finland in 1981-2000. Scand J Rheumatol. 2010;39(1):71–6.

Corresponding Author

Dr Rajesh V

Consultant Pulmonologist, Department of Pulmonary Medicine, Rajagiri Hospital, Aluva, Kerala, 683112

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile number: 9446728953, 0484- 29055039